title: Effects of nedocromil sodium, cromolyn sodium, and a placebo in exercise-induced asthma.
abstract: The incidence and severity of exercise-induced asthma were determined in nineteen asthmatic patients who performed eight minutes of exercise following four treatments administered in a random order. The treatments were nedocromil sodium, cromolyn sodium, placebo, and no treatment. It was concluded that nedocromil sodium (8 mg) and cromolyn sodium (4 mg) provide equal protection against exercise-induced asthma.
authors.affiliation: Department of Human Movement Studies, University of Western Australia, Nedlands.
authors.forename: A R
authors.initials: AR
authors.lastname: Morton
authors.forename: S L
authors.initials: SL
authors.lastname: Ogle
authors.forename: K D
authors.initials: KD
authors.lastname: Fitch
mesh_terms: D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D001250:Asthma, Exercise-Induced / Q000517:prevention & control*; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D005260:Female; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D008297:Male; D017835:Nedocromil; D010919:Placebos / Q000627:therapeutic use*; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use*; D012129:Respiratory Function Tests; D012720:Severity of Illness Index
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010919:Placebos; D015363:Quinolones; D017835:Nedocromil; D004205:Cromolyn Sodium